Huang LJ - Search Results

1

Effect of a potent cyclooxygenase inhibitor, 5-ethyl-4-methoxy-2-phenylquinoline (KTC-5), on human platelets.

Liao CH, Liao CH, Chang YL, Guh JH, Kuo SC, Huang LJ, Teng CM. Liao CH, et al. Among authors: huang lj. J Pharm Pharmacol. 2002 Jul;54(7):967-74. doi: 10.1211/002235702760089090. J Pharm Pharmacol. 2002. PMID: 12162716

2

Synthesis and antiplatelet activity of ethyl 4-(1-benzyl-1H-indazol-3-yl)benzoate (YD-3) derivatives.

Chen HS, Kuo SC, Teng CM, Lee FY, Wang JP, Lee YC, Kuo CW, Huang CC, Wu CC, Huang LJ. Chen HS, et al. Among authors: huang cc, huang lj. Bioorg Med Chem. 2008 Feb 1;16(3):1262-78. doi: 10.1016/j.bmc.2007.10.070. Epub 2007 Oct 25. Bioorg Med Chem. 2008. PMID: 17988878

3

Inhibition of Ras-mediated cell proliferation by benzyloxybenzaldehyde.

Pan SL, Guh JH, Huang YW, Chang YL, Chang CY, Huang LJ, Kuo SC, Teng CM. Pan SL, et al. Among authors: huang yw, huang lj. J Biomed Sci. 2002 Nov-Dec;9(6 Pt 2):622-30. doi: 10.1159/000067292. J Biomed Sci. 2002. PMID: 12432228

4

2-(3-Fluorophenyl)-6-methoxyl-4-oxo-1,4-dihydroquinoline-3-carboxylic acid (YJC-1) induces mitotic phase arrest in A549 cells.

Hsu MH, Chen CJ, Kuo SC, Chung JG, Lai YY, Teng CM, Pan SL, Huang LJ. Hsu MH, et al. Among authors: huang lj. Eur J Pharmacol. 2007 Mar 15;559(1):14-20. doi: 10.1016/j.ejphar.2006.12.001. Epub 2006 Dec 12. Eur J Pharmacol. 2007. PMID: 17223102

5

Synthesis of 2-alkoxy 1,4-naphthoquinone derivatives as antiplatelet, antiinflammatory, and antiallergic agents.

Lien JC, Huang LJ, Teng CM, Wang JP, Kuo SC. Lien JC, et al. Among authors: huang lj. Chem Pharm Bull (Tokyo). 2002 May;50(5):672-4. doi: 10.1248/cpb.50.672. Chem Pharm Bull (Tokyo). 2002. PMID: 12036028 Free article.

6

Anticancer mechanisms of YC-1 in human lung cancer cell line, NCI-H226.

Chen CJ, Hsu MH, Huang LJ, Yamori T, Chung JG, Lee FY, Teng CM, Kuo SC. Chen CJ, et al. Among authors: huang lj. Biochem Pharmacol. 2008 Jan 15;75(2):360-8. doi: 10.1016/j.bcp.2007.08.011. Epub 2007 Aug 17. Biochem Pharmacol. 2008. PMID: 17880926

7

YC-1 inhibits proliferation of breast cancer cells by down-regulating EZH2 expression via activation of c-Cbl and ERK.

Chang LC, Lin HY, Tsai MT, Chou RH, Lee FY, Teng CM, Hsieh MT, Hung HY, Huang LJ, Yu YL, Kuo SC. Chang LC, et al. Among authors: huang lj. Br J Pharmacol. 2014 Sep;171(17):4010-25. doi: 10.1111/bph.12708. Epub 2014 Jul 25. Br J Pharmacol. 2014. PMID: 24697523 Free PMC article.

8

1-Benzyl-3-(5'-hydroxymethyl-2'-furyl)indazole (YC-1) derivatives as novel inhibitors against sodium nitroprusside-induced apoptosis.

Lien JC, Lee FY, Huang LJ, Pan SL, Guh JH, Teng CM, Kuo SC. Lien JC, et al. Among authors: huang lj. J Med Chem. 2002 Nov 7;45(23):4947-9. doi: 10.1021/jm020070b. J Med Chem. 2002. PMID: 12408703

9

Synthesis of furopyrazole analogs of 1-benzyl-3-(5-hydroxymethyl-2-furyl)indazole (YC-1) as novel anti-leukemia agents.

Chou LC, Huang LJ, Yang JS, Lee FY, Teng CM, Kuo SC. Chou LC, et al. Among authors: huang lj. Bioorg Med Chem. 2007 Feb 15;15(4):1732-40. doi: 10.1016/j.bmc.2006.12.001. Epub 2006 Dec 6. Bioorg Med Chem. 2007. PMID: 17189698

10

Synthesis of N2-(substituted benzyl)-3-(4-methylphenyl)indazoles as novel anti-angiogenic agents.

Huang LJ, Shih ML, Chen HS, Pan SL, Teng CM, Lee FY, Kuo SC. Huang LJ, et al. Bioorg Med Chem. 2006 Jan 15;14(2):528-36. doi: 10.1016/j.bmc.2005.08.032. Epub 2005 Oct 3. Bioorg Med Chem. 2006. PMID: 16202611

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

653 results

Search Page

Filters